海马脑片缺氧损伤电位

在脑缺血／缺氧损伤研究领域,离体海马脑片的应用日益普遍,在海马脑片缺氧过程中,发现ＣＡ１区诱发群锋电位及场兴奋性突触后电位消失后又自行恢复,这就是海马脑片缺氧损伤电位,本文介绍了ＨＩＰ的电生理特性,代表的意义及可能的产生机制。     

海马脑片缺氧早期腺苷的作用及其机制研究

本实验采用海马脑片细胞外记录技术,观察了缺氧早期突触功能可逆性抑制中腺苷的作用并初步探讨其作用机制。结果发现：海马脑片缺氧早期突触功能出现可逆性抑制,与外源施加高浓度腺苷反应类同。腺苷Ａ１受体拮抗剂ＣＰＴ以及Ｋ＋通道阻断剂４－ＡＰ可阻断这种抑制作用;而ＴＥＡ以及ＡＴＰ敏感Ｋ＋通道阻断剂ｇｌｉｐｉｚｉｄｅ均未见显著效应。结果提示：缺氧早期突触功能可逆性抑制与内源性腺苷大量释放有关,腺苷通过作用其Ａ１受体,激活４－ＡＰ敏感Ｋ＋通道,从而抑制突触传递,显示其抗缺氧作用。ＡＴＰ敏感性Ｋ＋通道可能不参于这个过程。     

重复缺氧与过氧化氢对脑与突触体乳酸生成的影响

目的：观察重复缺氧对小鼠在体脑乳酸含量以及Ｈ２Ｏ２对荷兰猪离体突触体乳酸含量的影响,并分析其作用机制。方法：采用酶氧化方法对突触体培养液中乳酸含量进行测定。结果：单次急性缺氧鼠脑内乳酸含量高,但在重复缺氧的作用下,鼠脑内乳酸的含量并未随缺氧时间的延长而增加。在突触体培养液中分别加入Ｈ２Ｏ２、ＦＣＣＰ、Ｒｏｔｅｎｏｎ,乳酸浓度比正常对照组显著性的增高。对突触体进行长时间Ｈ２Ｏ２处理,乳酸含量未见显著升高或降低。同时在突触体培养液中加入Ｈ２Ｏ２和ＦＣＣＰ,乳酸浓度相当于单独在突触体培养液分别加入Ｈ２Ｏ２与ＦＣＣＰ产生乳酸之和。结论：重复缺氧与Ｈ２Ｏ２处理可能激发脑与突触体内的抗自由基损伤防御系统;突触体从有氧呼吸到无氧酵解的转换主要不是由于Ｈ２Ｏ２对突触体膜的损伤。     

慢性缺氧对大鼠膈肌组织化学和超微结构影响的研究

研究慢性缺氧和参麦注射液治疗对大鼠膈肌组织化学和超微结构的影响,结果显示：缺氧使膈肌ＳＤＨ活性降低,Ⅰ类纤维极显著减少,运动终板ＣｈＥ活性极显著降低,线粒体肿胀变性,神经肌肉运动终板突触前部囊泡减少,突触间隙模糊,终板模电子密度降低;参麦治疗可恢复缺氧膈肌的ＳＤＨ活性及Ⅰ类纤维数目,显著提高终板ＣｈＥ活性,线粒体结构恢复正常,运动终板突触前部囊泡丰富,突触间隙清晰,终板膜电子密度正常。表明慢性缺氧降低膈肌有氧氧化能力,影响其能量代谢及神经冲动的传递,从而减弱其收缩力,而参安治疗可改善缺氧造成的上述损害,为其临床应用提供了实验医学依据。     

金属硫蛋白对缺氧／复氧心肌细胞的保护作用

金属硫蛋白 (ＭＴ)是普遍存在各种生物体内、富含硫基的小分子蛋白 ,在缺血 /再灌注 (Ｉ/Ｒ)损伤中通过清除自由基减轻心肌细胞损伤 ,同时ＭＴ参与预缺血保护 (ＩＰＣ)。目前对ＭＴ在ＩＰＣ中的保护作用机制及功效仍无明确研究 ,本实验以培养的乳鼠心肌细胞缺氧 /复氧模拟缺血 /再灌注损伤 ,检测心肌细胞在ＩＰＣ处理后 2 4ｈＭＴ的含量、脂质过氧化程度及Ｎａ Ｋ ＡＴＰ酶、Ｃａ2 Ｍｇ2 ＡＴＰ酶的活力变化 ,锌诱导产生的ＭＴ作用 ,并比较ＭＴ与抗氧化剂谷胱甘肽 (ＧＳＨ)的保护作用 ,初步探讨ＭＴ的心肌保护作用机制及应用价值。1　…     

缺氧条件下冻伤对大鼠微循环血液灌流量的影响

本文采用体重２００±２０ｇ健康雄性Ｗｉｓｔａｒ大鼠,随机分为平原冻伤（ＦＮ）组、急性缺氧冻伤（ＦＡＨ）组和缺氧习服缺氧冻伤（ＦＨＡＣ）组,实验观察了大鼠右后肢重度冻伤前后各组大鼠双后肢皮肤微循环灌流量的改变。结果表明,平原冻伤使大鼠双后肢微循环灌流量明显减少,提示局部重度冻伤对微循环的影响不只局限于冻区也涉及到对侧肢体。冷冻前ＦＡＨ组大鼠微循环灌流量已明显低于ＦＮ组,表明急性缺氧时血容量进行代偿性的再分配,使微循环灌流量减少;ＦＡＨ组大鼠冻后双后肢微循环灌流量的改变结果提示急性缺氧可加重其冻伤对微循环的损伤程度。ＦＨＡＣ组大鼠冻前微循环灌流量非常明显地低于正常对照,也明显低于急性缺氧对照,表明缺氧习服可造成微循环障碍;ＦＨＡＣ组大鼠冻肢微循环灌流量非常明显地低于ＦＮ组,提示缺氧习服加重高原冻伤引起的微循环障碍。     

AMPA受体与阿尔茨海默病

AMPA受体(α-amino-3-hydroxy-5-methyl-4-isoxa-zolep-propionate receptor,AMPAR)介导中枢神经系统快速兴奋性突触传递,其在突触后膜的动态表达与长时程增强、长时程抑制的诱发和维持有关,参与调节学习记忆活动。AMPAR在β-淀粉样蛋白作用下的过度胞吞和裂解致其在突触后膜缺失,可致突触损伤和功能障碍,与阿尔茨海默病早期认知障碍密切相关。AMPAR还参与谷氨酸介导的兴奋性损伤,Ca2+通透性AMPAR亚型的过度激活能导致阿尔茨海默病神经元的功能障碍甚至死亡。此外,AMPAR还参与tau蛋白的异常磷酸化,与神经原纤维缠结的形成有关。因而突触后膜AMPA受体数目和功能异常可能是导致阿尔兹海默病发生的重要环节。     

鼠脑突触体Mg^2＋—ATP酶质子泵活性的研究

位于突触体质膜的外向型（ｅｃｔｏ）Ｍｇ＾２－ＡＴＰ酶具有水解ＡＴＰ活性,能量偶联的ＡＣ－ＭＡ荧光淬灭实验表明Ｍｇ＾２＋－ＡＴＰ酶水解ＡＴＰ时向膜内转移质子,建立跨膜质子梯度,跨膜质子梯度可以被电中性Ｋ＾＋／Ｈ＾＋离子载体Ｎｉｇｅｒｉｃｉｎ消除,利用Ｈ＾＋敏感的ＢＣＥＣＦ荧光分子测定突触的ｐＨｉ变化,结果表明水解ＡＴＰ产生的质子转移突触体ｐＨｉ下降了光分子测定突触的ｐＨｉ变化,结果表示水解ＡＴＰ产生     

以突触前排放的消失设定海马脑片缺氧损伤时间及应用实例

刺激Schaffer侧支,记录大鼠海马脑片CA_1区的突触前排放(presynaptic volley,PV)和突触后群锋电位(population spikes,PS),观察缺氧后PS和PV的变化及复氧30min后脑片PS的恢复,缺氧持续到PV消失1,2,3或4min,复氧后脑片恢复率分别为100％,11.5％,0％,0％。可见,缺氧后 PV 消失2min为损伤的关键时刻。提前1min终止缺氧,全部脑片的PS可以恢复,延迟1min终止缺氧,则全部脑片的PS不能恢复。这种方法是根据每个脑片的电反应确定其总的缺氧时间,故每个脑片的缺氧时间略有变动。与每次采用相同缺氧时间的传统方法相比,此方法脑片恢复率的稳定性与重复性均较好。用此方法发现美西律10和100μmol/L能增加复氧后PS恢复率,对突触功能的缺氧损伤具有保护作用。     

缺氧对大鼠海马脑片诱发电位的影响

在脑缺氧损伤的研究中,离体海马切片既可排除血脑屏障,又保持原有神经环路,所得实验结果接近在体实验,是研究脑缺氧的理想模型。近几年来国外已有人报道了缺氧时海马脑片诱发电位的变化;但同时用两个脑片比较不同程度的低氧对脑片诱发电位的影响,却少有报道。本实验采用自行设计的双孔脑片电生理实验系统,用不同浓度的低氧混合气造成不同程度的缺氧环境,以探明不同缺氧程度影响脑片电反应的时间曲线,寻求海马脑片缺氧损伤的特征性反应与不可逆损伤发生的临界值。     

低氧预适应增强大鼠海马神经元的耐缺氧能力

本研究对整体大鼠进行了模拟不同海拔高度（3000、5000m）的低氧预适应,然后观察了急性致死性缺氧对这些大鼠海马脑片诱发群锋电位的影响。结果显示,经低氧预适应的大鼠其海马脑片在给予急性缺氧后,CA1区缺氧损伤电位（hypoxic injury potential,HIP）出现时间以及突触前排放（presynaptic volley,PV）消失时间均明显延迟;其中5000m预适应组的延迟程度比3000m组明显。复氧后,PV的恢复率在3000m和5000m低氧预适应组均明显高于对照组。本研究结果提示,整体动物的低氧预适应可以增强离体海马脑片神经元的耐缺氧能力。     

Structural abnormalities in spermatids together with reduced sperm counts and motility underlie the reproductive defect in HIP1-/- mice

Huntingtin interacting protein 1 (HIP1) is an endocytic adaptor protein with clathrin assembly activity that binds to cytoplasmic proteins, such as F-actin, tubulin, and huntingtin (htt). To gain insight into diverse functions of HIP1, we characterized the male reproductive defect of HIP1(-/-) mice from 7 to 30 weeks of age. High levels of HIP1 protein were expressed in the testis of wild-type mice as seen by Western blots and as a reaction over Sertoli cells and elongating spermatids as visualized by immunocytochemistry. Accordingly, major structural abnormalities were evident in HIP1(-/-) mice with vacuolation of seminiferous tubules caused by an apparent loss of postmeiotic spermatids and a significant reduction in mean profile area. Remaining spermatids revealed deformations of their heads, flagella, and/or acrosomes. In some Sertoli cells, ectoplasmic specializations (ES) were absent or altered in appearance accounting for the presence of spherical germ cells in the epididymal lumen. Quantitative analyses of sperm counts from the cauda epididymidis demonstrated a significant decrease in HIP1(-/-) mice compared to wild-type littermates. In addition, computer-assisted sperm analyses indicated that velocities, amplitude of lateral head displacements (ALH), and numbers and percentages of sperm in the motile, rapid, and progressive categories were all significantly reduced in HIP1(-/-) mice, while the numbers and percentages of sperm in the static category were greatly increased. Taken together, these various abnormalities corroborate reduced fertility levels in HIP1(-/-) mice and suggest a role for HIP1 in stabilizing actin and microtubules, which are important cytoskeletal elements enabling normal spermatid and Sertoli cell morphology and function.     

Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking

Huntingtin interacting protein 1 (HIP1) is a recently identified component of clathrin-coated vesicles that plays a role in clathrin-mediated endocytosis. To explore the normal function of HIP1 in vivo, we created mice with targeted mutation in the HIP1 gene (HIP1(-/-)). HIP1(-/-) mice develop a neurological phenotype by 3 months of age manifest with a failure to thrive, tremor and a gait ataxia secondary to a rigid thoracolumbar kyphosis accompanied by decreased assembly of endocytic protein complexes on liposomal membranes. In primary hippocampal neurons, HIP1 colocalizes with GluR1-containing AMPA receptors and becomes concentrated in cell bodies following AMPA stimulation. Moreover, a profound dose-dependent defect in clathrin-mediated internalization of GluR1-containing AMPA receptors was observed in neurons from HIP1(-/-) mice. Together, these data provide strong evidence that HIP1 regulates AMPA receptor trafficking in the central nervous system through its function in clathrin-mediated endocytosis.     

HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains

Huntingtin-interacting protein 1-related (HIP1r) is the only known mammalian relative of huntingtin-interacting protein 1 (HIP1), a protein that transforms fibroblasts via undefined mechanisms. Here we demonstrate that both HIP1r and HIP1 bind inositol lipids via their epsin N-terminal homology (ENTH) domains. In contrast to other ENTH domain-containing proteins, lipid binding is preferential to the 3-phosphate-containing inositol lipids, phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,5-bisphosphate. Furthermore, the HIP1r ENTH domain, like that of HIP1, is necessary for lipid binding, and expression of an ENTH domain-deletion mutant, HIP1r/deltaE, induces apoptosis. Consistent with the ability of HIP1r and HIP1 to affect cell survival, full-length HIP1 and HIP1r stabilize pools of growth factor receptors by prolonging their half-life following ligand-induced endocytosis. Although HIP1r and HIP1 display only a partially overlapping pattern of protein interactions, these data suggest that both proteins share a functional homology by binding 3-phosphorylated inositol lipids and stabilizing receptor tyrosine kinases in a fashion that may contribute to their ability to alter cell growth and survival.     

Huntingtin-Interacting Protein 1 Phosphorylation by Receptor Tyrosine Kinases

Huntingtin-interacting protein 1 (HIP1) binds inositol lipids, clathrin, actin, and receptor tyrosine kinases (RTKs). HIP1 is elevated in many tumors, and its expression is prognostic in prostate cancer. HIP1 overexpression increases levels of the RTK epidermal growth factor receptor (EGFR) and transforms fibroblasts. Here we report that HIP1 is tyrosine phosphorylated in the presence of EGFR and platelet-derived growth factor β receptor (PDGFβR) as well as the oncogenic derivatives EGFRvIII, HIP1/PDGFβR (H/P), and TEL/PDGFβR (T/P). We identified a four-tyrosine “HIP1 phosphorylation motif” (HPM) in the N-terminal region of HIP1 that is required for phosphorylation mediated by both EGFR and PDGFβR but not by the oncoproteins H/P and T/P. We also identified a tyrosine residue (Y152) within the HPM motif of HIP1 that inhibits HIP1 tyrosine phosphorylation. The HPM tyrosines are conserved in HIP1''s only known mammalian relative, HIP1-related protein (HIP1r), and are also required for HIP1r phosphorylation. Tyrosine-to-phenylalanine point mutations in the HPM of HIP1 result in proapoptotic activity, indicating that an intact HPM may be necessary for HIP1''s role in cellular survival. These data suggest that phosphorylation of HIP1 by RTKs in an N-terminal region contributes to the promotion of cellular survival.     

Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI)

Huntington's disease is a genetic neurological disorder that is triggered by the dissociation of the huntingtin protein (htt) from its obligate interaction partner Huntingtin-interacting protein 1 (HIP1). The release of the huntingtin protein permits HIP1 protein interactor (HIPPI) to bind to its recognition site on HIP1 to form a HIPPI/HIP1 complex that recruits procaspase-8 to begin the process of apoptosis. The interaction module between HIPPI and HIP1 was predicted to resemble a death-effector domain. Our 2.8-Å crystal structure of the HIP1 371-481 subfragment that includes F432 and K474, which is important for HIPPI binding, is not a death-effector domain but is a partially opened coiled coil. The HIP1 371-481 model reveals a basic surface that we hypothesize to be suitable for binding HIPPI. There is an opened region next to the putative HIPPI site that is highly negatively charged. The acidic residues in this region are highly conserved in HIP1 and a related protein, HIP1R, from different organisms but are not conserved in the yeast homologue of HIP1, sla2p. We have modeled ∼ 85% of the coiled-coil domain by joining our new HIP1 371-481 structure to the HIP1 482-586 model (Protein Data Bank code: 2NO2). Finally, the middle of this coiled-coil domain may be intrinsically flexible and suggests a new interaction model where HIPPI binds to a U-shaped HIP1 molecule.     

Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors

Huntingtin-interacting protein 1 (HIP1) interacts with huntingtin, the protein whose gene is mutated in Huntington's disease. In addition, a fusion between HIP1 and platelet-derived growth factor beta receptor causes chronic myelomonocytic leukemia. The HIP1 proteins, including HIP1 and HIP1-related (HIP1r), have an N-terminal polyphosphoinositide-interacting epsin N-terminal homology, domain, which is found in proteins involved in clathrin-mediated endocytosis. HIP1 and HIP1r also share a central leucine zipper and an actin binding TALIN homology domain. Here we show that HIP1, like HIP1r, colocalizes with clathrin coat components. We also show that HIP1 physically associates with clathrin and AP-2, the major components of the clathrin coat. To further understand the putative biological role(s) of HIP1, we have generated a targeted deletion of murine HIP1. HIP1(-/-) mice developed into adulthood, did not develop overt neurologic symptoms in the first year of life, and had normal peripheral blood counts. However, HIP1-deficient mice exhibited testicular degeneration with increased apoptosis of postmeiotic spermatids. Postmeiotic spermatids are the only cells of the seminiferous tubules that express HIP1. These findings indicate that HIP1 is required for differentiation, proliferation, and/or survival of spermatogenic progenitors. The association of HIP1 with clathrin coats and the requirement of HIP1 for progenitor survival suggest a role for HIP1 in the regulation of endocytosis.     

DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI3K/AKT pathway

Pancreatic cancer (PAAD) is a highly malignant tumour characterized of high mortality and poor prognosis. Huntingtin-interacting protein 1-related (HIP1R) has been recognized as a tumour suppressor in gastric cancer, while its biological function in PAAD remains to be elucidated. In this study, we reported the downregulation of HIP1R in PAAD tissues and cell lines, and the overexpression of HIP1R suppressed the proliferation, migration and invasion of PAAD cells, while silencing HIP1R showed the opposite effects. DNA methylation analysis revealed that the promoter region of HIP1R was heavily methylated in PAAD cell lines when compared to the normal pancreatic duct epithelial cells. A DNA methylation inhibitor 5-AZA increased the expression of HIP1R in PAAD cells. 5-AZA treatment also inhibited the proliferation, migration and invasion, and induced apoptosis in PAAD cell lines, which could be attenuated by HIP1R silencing. We further demonstrated that HIP1R was negatively regulated by miR-92a-3p, which modulates the malignant phenotype of PAAD cells in vitro and the tumorigenesis in vivo. The miR-92a-3p/HIP1R axis could regulate PI3K/AKT pathway in PAAD cells. Taken together, our data suggest that targeting DNA methylation and miR-92a-3p-mediated repression of HIP1R could serve as novel therapeutic strategies for PAAD treatment.     

Singular over-representation of an octameric palindrome, HIP1, in DNA from many cyanobacteria.

An octameric palindrome (5'-GCGATCGC-3') is abundant in cyanobacterial sequences within databases (GenBank/EMBL) and was designated HIP1 (highly iterated palindrome). The frequency of occurrence of all 256 octameric palindromes has now been determined in sub-databases revealing large and unique over-representation of HIP1 in cyanobacterial entries. DNA sequences from other bacteria were searched for any over-represented octameric palindromes analogous to HIP1. Only two sequences were identified, in the genomes of a thermophile and halophilic archaebacteria, although these were less abundant than HIP1 in cyanobacteria and relate to codon usage. To test the proposed widespread distribution of HIP1 in DNA from the cyanobacterium Synechococcus PCC 6301, randomly selected genomic clones were partly sequenced. HIP1 constituted 2.5% of the novel sequences, equivalent to a site on average once every 320 nucleotides. An oligonucleotide including HIP1 was also tested in PCR. Multiple products were obtained using template DNA from cyanobacterial strains in which HIP1 is abundant in known sequences, and some strains generated characteristic HIP-PCR banding patterns. However, analysis of DNA from one strain (not previously represented in databases) by random sequencing, HIP-PCR and Pvul digestion, confirms that not all cyanobacterial genomes are rich in HIP1.     

Multiple domains contribute to heparin/heparan sulfate binding by human HIP/L29

Human heparin/heparan sulfate interacting protein/L29 (HIP/L29) is thought to be involved in the promotion of cell adhesion, the promotion of cell growth in the cancerous state, and the modulation of blood coagulation. These activities are consistent with the proposed function of HIP/L29 as a heparin/heparan sulfate (Hp/HS) binding growth factor that has a preference for anticoagulantly active Hp/HS. Previous studies showed that a peptide derived from the C terminus of human HIP/L29 (HIP peptide-1) can selectively bind anticoagulant Hp and support cell adhesion. However, a murine ortholog does not have an identical HIP peptide-1 sequence, yet still retains the ability to bind Hp, suggesting that there may be additional Hp/HS binding sites outside of the HIP peptide-1 domain. To test this hypothesis, a systematic study of the domains within human and murine HIP/L29 responsible for Hp/HS binding activity was undertaken. Using deletion mutants, proteolytic fragments, and protease protection of HIP/L29 by Hp, we demonstrate that multiple binding domains contribute to the overall Hp/HS binding activity of HIP/L29 proteins. Furthermore, a conformational change is induced in human HIP/L29 upon Hp binding as detected by circular dichroism spectroscopy. These studies demonstrate the multiplicity of Hp/HS binding sequences within human and murine HIP/L29.